ArticleNature communications2022

Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617.

Lei Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.